Red Nucleus Named to the 2026 MM+M Agency 100

Recognition Highlights Red Nucleus’ Leadership in Life Sciences Commercialization

YARDLEY, Penn.--(BUSINESS WIRE)-- Red Nucleus, a leading, global provider of strategic services and solutions across the life sciences product lifecycle, today announced its inclusion in the 2026 MM+M Agency 100, the annual ranking of the most influential healthcare marketing and communications agencies in North America. Published by MM+M (Medical Marketing + Media), the Agency 100 recognizes organizations that are shaping the future of healthcare communications through innovation, scientific expertise, strategic insight, and measurable client impact.

“We are honored to be recognized by MM+M as part of the Agency 100,” said Mike Menta, Chief Executive Officer of Red Nucleus. “This recognition reflects the extraordinary talent, passion, and commitment of our global team. As the healthcare landscape continues to evolve, we remain focused on helping our clients navigate complexity, accelerate commercialization, and ultimately improve outcomes for patients around the world.”

With operations across North America, Europe, Asia, and Latin America, Red Nucleus partners with life sciences organizations at every stage of the commercialization journey. The company supports many of the industry's leading pharmaceutical and biotechnology organizations through integrated capabilities spanning Medical Affairs, Value & Evidence, Commercial, Research and Development, and Learning & Development.

The recognition underscores Red Nucleus’ continued growth and leadership in supporting life sciences organizations across the commercialization journey.

To read Red Nucleus’ full profile in the 2026 MM+M Agency 100, visit:

HTTPS://WWW.MMM-ONLINE.COM/COMPANYDETAIL/RED-NUCLEUS-AGENCY-100-2026/

About Red Nucleus

Red Nucleus is a global strategic partner trusted to deliver transformative solutions across the entire life sciences product lifecycle. By connecting its full suite of products and services, Red Nucleus serves clients through transformational change to accelerate success. With expertise spanning Medical Affairs, Value & Evidence, Commercial, Research and Development, and Learning & Development, Red Nucleus helps life sciences organizations bring therapies to market and maximize their impact on patients worldwide. Guided by its vision of improving the health of patients around the world by solving healthcare’s most pressing challenges, Red Nucleus advances knowledge to improve lives.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260617486810/en/

Media Inquiries
Mary Kilmartin
[email protected]

Source: Red Nucleus

You May Also Be Interested In

• Dataminr Launches First Alert Advanced and Secures Landmark $318 Million Contract with the U.S. Department of War
• Lomiko Metals Announces Receipt of Interim Court Order and Mailing of Management Information Circular Relating to Arrangement With Global Battery Materials
• KBRA Assigns and Affirms Ratings for Mandatory Redeemable Preferred Shares Issued by Calamos Dynamic Convertible and Income Fund